Vitamin K2 Market

Report Code FB 9049
Published in Jan, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Vitamin K2 Market by Product Type (MK-4, MK-7), Form (Capsules & Tablets, Powder & Crystalline, Oils & Liquid), Application (Pharmaceutical, Functional Food & Beverages, Health Supplements), by Function (Bone & Cardiovascular Health, Blood Health & Clotting, Anti-Inflammatory & Immune Support, Other Functions) - Global Forecast to 2029

Overview

The market for vitamin K2 is estimated at USD 139.6 million in 2024; it is projected to grow at a CAGR of 13.7% to reach USD 264.7 million by 2029. As scientific research continues to highlight the benefits of Vitamin K2, particularly in calcium metabolism and the prevention of arterial calcification, more individuals are incorporating this nutrient into their diets. This heightened awareness is especially prevalent among aging populations, who are at greater risk for osteoporosis and cardiovascular diseases, thereby fueling demand for Vitamin K2 supplements.

Another significant contributor to market expansion is the rise of the health and wellness trend. Consumers worldwide are becoming more proactive about their health, seeking preventive measures to avoid chronic diseases. This shift is evident in the growing popularity of dietary supplements and functional foods fortified with essential nutrients like Vitamin K2.

Vitamin K2 Market Overview

Attractive Opportunities in the Vitamin K2 Market

ASIA PACIFIC:

The growing awareness of the benefits of preventive healthcare is a major driving factor for the Vitamin K2 market. Consumers are increasingly informed about the importance of maintaining bone and cardiovascular health to prevent conditions such as osteoporosis and heart disease.

Rapid economic growth and urbanization in countries like China, India, and Southeast Asia are leading to higher disposable incomes. This economic shift enables more consumers to afford premium products, including those with clean label claims.

Collaborations, Acquisitions, and new product launches are expected to present profitable prospects for industry participants in the coming five years. Moreover, with the rise of health-conscious lifestyles, there is a growing demand for dietary supplements and functional foods that support overall well-being.

The shift towards proactive health management is boosting the demand for Vitamin K2 supplements, which are recognized for their critical role in calcium metabolism and arterial health.

The market for vitamin K2 is projected to record a CAGR of 13.7% during the study period, to reach USD 264.7 million by 2029. 

Global Vitamin K2 Market Dynamics

Drivers: Rising health consciousness among consumers

With the shift in demand from processed to healthy food, functional, and superfoods, consumers have become more conscious of their health and maintain it proactively through healthy living. Consumers are more aware of the food ingredients and pay attention to nutrition labels, ingredients of the food products, adequate intake (AI), and recommended dietary allowance (RDA). This change in buying habits has resulted in a higher demand for healthy foods and supplements and has attracted several manufacturers to offer new food products that are functional, not genetically modified, and sourced naturally.

With the increasing consciousness and concern about health and wellness, demand for multifunctional menaquinones or vitamin K2 is expected to increase in the coming years. Governments around the world have also recognized the potential health benefits of vitamin K2 and are taking steps to promote its consumption. Recent research has strengthened the link between vitamin K2 and cardiovascular health. Governments around the world have also recognized these benefits and are taking steps to promote its consumption. A 2019 genetic study by NIH (National Institutes of Health) involving over 103,000 European participants found that while vitamin K1 showed no impact on arterial calcification, vitamin K2 positively influenced cardiovascular health by activating matrix Gla-protein (MGP), a potent inhibitor of arterial calcification.

RESTRAINTS: Inconsistency in regulatory norms

The Vitamin K2 market faces significant challenges due to inconsistent regulatory norms across different global jurisdictions. These regulatory variations create complex barriers for manufacturers, including diverse approval processes, safety standards, and labeling requirements that complicate market entry and expansion. In the US, vitamin K2 supplements are regulated as dietary supplements by the Food and Drug Administration (FDA), while vitamin K2-containing foods are regulated by the US Department of Agriculture (USDA) and the FDA. For instance, dietary supplements must comply with the Dietary Supplement Health and Education Act (DSHEA) of 1994, which outlines specific requirements for labeling, safety, and manufacturing practices. Foods fortified with vitamin K2 must adhere to regulations pertaining to food additives and nutrient fortification under both the USDA and FDA's jurisdiction.

In the European Union, vitamin K2-containing foods and supplements are regulated by the European Food Safety Authority (EFSA), while in other countries, such as Korea, it is still under approval by South Korea’s Ministry of Drug and Food Safety (MFDS). The EFSA has approved health claims for vitamin K2 related to bone and cardiovascular health, but the process of gaining approval can be lengthy and costly, involving rigorous scientific evaluation and evidence submission. Companies must provide substantial clinical data to substantiate health claims, which can be a resource-intensive process.

This inconsistency in regulatory norms can make it challenging for companies to bring vitamin K2-containing products to market, as they may need to navigate different regulatory requirements in different countries or regions. This can increase the time and cost of product development and may limit the availability of vitamin K2-containing products in some markets.

OPPORTUNITIES: Growing demand for natural and plant-based ingredients

In the coming years, emerging countries, such as China, India, and some countries in the Middle East & Africa, are expected to experience a sharp upsurge in demand for vitamin K2 extracted from different raw materials. This demand is expected to be driven by an increase in the consumption of healthy foods, functional foods, and vitamin supplements. In addition, these regions also provide cost optimization in terms of production, labor cost, and processing. High demand, coupled with a low cost of production, is a key feature that is expected to support vitamin K2 or menaquinone manufacturers to enter into new geographies.

Challenges: Lack of consumer awareness regarding specific health benefits of Vitamin K2

The lack of awareness of vitamin K2 and its potential applications is a significant challenge for the industry. Many consumers and food manufacturers may not be familiar with vitamin K2, which can limit the demand for menaquinone-containing products and hinder the growth of the market.

A study published in the Journal of Pharmaceutical Research International in 2020 found that while consumers were generally aware of the health benefits of vitamin K, they were less familiar with the specific health benefits of vitamin K2. The study suggested that increasing consumer awareness of vitamin K2’s health benefits could be a way to increase demand for menaquinone-containing products.

Global Vitamin K2 Market Ecosystem Analysis

Prominent companies in this market include well-established, financially stable manufacturers of Vitamin K2. These companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-Oil Mills, INC. (PLT Health Solutions, Inc.) (Japan), Novozymes A/S, part of Novonesis Group (Denmark), Sungen Bioscience Co., Ltd. (China), GF Fermentech (GenoFocus) (Korea), AngelYeast Co., Ltd. (China), among others.

Vitamin K2 Market Ecosystem
 

Based on product type, the MK 7 segment is projected to be the dominating segment in the market.

Vitamin K2 MK-7, specifically MenaQ7 and vitaMK7, represents a pivotal advancement in nutritional science, renowned for its dual benefits in bone and cardiovascular health. Distinct from its K1 counterpart, K2 MK-7's superior bioavailability and extended half-life in the body make it optimal for promoting calcium utilization towards bone strength while preventing arterial calcification. Its role in activating key proteins like osteocalcin and Matrix Gla Protein (MGP) underscores its efficacy in supporting skeletal integrity and cardiovascular flexibility.

As consumer awareness grows and dietary deficiencies persist, the market potential for K2 MK-7 continues to expand, driven by increasing demand for scientifically validated supplements that address fundamental health challenges across diverse demographic segments.

The pharmaceutical segment in the vitamin K2 market is projected to have a significant growth in the forecasted period.

Vitamin K2 has shown various potential benefits in pharmaceutical applications, which are estimated to drive the demand for this ingredient in this industry. However, there is a stringent regulatory structure for the usage of vitamin K2 in pharmaceutical applications across the regions. Multiple primary industry experts from various vitamin K2 manufacturers agreed that the usage of vitamin K2 in pharmaceutical applications is limited to Asia Pacific; within this region, although some countries manufacture vitamin K2 for pharmaceutical applications, the consumption is mainly observed in China and Japan. Thus, considering, recent government insights, along with ongoing research and clinical trials, support the potential benefits of vitamin K2 in pharmaceutical applications.

Asia Pacific is the fastest-growing market for vitamin K2 among the regions.

The Asia Pacific region is emerging as the fastest-growing market for Vitamin K2, driven by a combination of demographic, economic, and lifestyle factors. One of the primary drivers of this growth is the region’s rapidly aging population. Countries such as Japan, China, and South Korea are experiencing significant increases in their elderly populations, who are more prone to bone-related ailments like osteoporosis and cardiovascular issues. This demographic shift is creating a substantial demand for nutritional supplements that support bone health and prevent arterial calcification, making Vitamin K2 a sought-after nutrient.

Additionally, The robust growth of the e-commerce sector in the Asia Pacific (APAC) region has significantly facilitated easy access to a wide range of Vitamin K2 products, contributing to the market's expansion. One of the main advantages is the proliferation of online retail platforms, such as Amazon, Alibaba, and other regional e-commerce giants. These platforms have not only increased the visibility of Vitamin K2 supplements but have also allowed for a broader distribution network, reaching consumers in even the most remote areas.

HIGHEST CAGR MARKET IN 2024 - 2029
CHINA FASTEST GROWING MARKET IN THE REGION
Vitamin K2 Market by Region

Recent Developments of Vitamin K2 Market industry

  • In September 2024, Gnosis by Lesaffre highlighted MenaQ7 Vitamin K2 during Denk Ingredient’s Annual Symposium in Munich, Germany. The presentation emphasized MenaQ7’s critical role in supporting women’s health through all life stages, from improving bone mineral density and strength during peak bone-building years to reducing arterial stiffness for cardiovascular health post-menopause. With K2 deficiencies prevalent in modern diets, MenaQ7 offers an easy and clinically proven solution for comprehensive bone and heart support.
  • In August 2023, Richen Nutritional Technology Co., ltd. introduced a new addition to its RiviK2 series—Vitamin K2 (fermented) micro-encapsulated powder. This innovative product is designed to enhance bone health by offering improved application performance and stability. 
  • In July 2023, GF Fermentech entered into a strategic partnership with Kregliner & Barentz, a global leader in bio-health care distribution, to enhance the global reach and visibility of its Vitamin K2 (VK2) products. This collaboration focuses on expanding the sales channels and brand awareness of MediQ7, GF Fermentech’s naturally fermented and health-benefiting VK2 product.
  • In April 2022, GF Fermentech, a subsidiary of Genofocus, introduced a higher-purity variant of its MediQ7 range of vitamin K2 ingredients, named MediQ7 Pure. Derived from Bacillus subtilis natto sourced from traditional Korean fermented food Cheonggukjang, this product boasts over 96% concentration and 99.9% trans-type Menaquinone 7, aligning with USP standards. The ingredients are vegan, kosher, halal, GMP, ISO 9001, and ISO 22000 certified.
  • In January 2021, Menadiona launched its Vitamin K2 MK-7 grade. Menadiona has been a consistent supplier of Vitamin K2 MK-4 (Menatetrenone) for the medical treatment of osteoporosis. With the COVID-19 pandemic highlighting a potential link between Vitamin K2 deficiency and the risk of developing the disease, MENADIONA has expanded its product line to include the new MK-7 grade, suitable for nutraceutical formulations in various forms, such as gel, oil, or capsules.

Key Market Players

KEY PLAYERS IN THE Vitamin K2 Market INCLUDE

Other players in the market includes GeneFerm Biotechnology Co., Ltd. (Taiwan), Nakoda Chemical Ltd. (India), Haihang Industry Co.,Ltd. (China), Chemicea Limited (India), and Kyowa Hakko U.S.A., Inc. (US).
 
These market players are focusing on increasing their presence through agreements and collaborations. These companies have a strong presence in North America, Asia Pacific, and Europe. They also have manufacturing facilities along with strong distribution networks across these regions.

Want to explore hidden markets that can drive new revenue in Vitamin K2 Market?

Scope of the Report

Report Attribute Details
Market size value in 2024 USD 139.6 million
Revenue forecast in 2029 USD 264.7 million
Growth Rate CAGR of 13.7% from 2024 to 2029
Market size estimation 2024–2029
Base year considered 2023
Forecast period considered 2024–2029
Units considered Value (USD Million), Volume (Tons)
Segments Covered By Product Type, Form, Source, Application, Function, and Region
Regions covered North America, Europe, Asia Pacific, and RoW
Companies studied Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-Oil Mills, INC. (PLT Health Solutions, Inc.) (Japan), Novozymes A/S, part of Novonesis Group (Denmark), Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), GF Fermentech (GenoFocus) (Korea), AngelYeast Co., Ltd. (China), GeneFerm Biotechnology Co., Ltd. (Taiwan), Nakoda Chemical Ltd. (India), Haihang Industry Co., Ltd. (China), Chemicea Limited (India), Kyowa Hakko U.S.A., Inc. (US) 

 

Key Questions Addressed by the Report

What is the current size of the vitamin K2 market?
The vitamin K2 market is estimated at USD 139.6 million in 2024 and is projected to reach USD 264.7 million by 2029, at a CAGR of 13.7% from 2024 to 2029.
Which are the key players in the market, and how intense is the competition?
The key players in the vitamin K2 market include Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-Oil Mills, INC. (PLT Health Solutions, Inc.) (Japan), Novozymes A/S, part of Novonesis Group (Denmark), Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), GF Fermentech (GenoFocus) (Korea), AngelYeast Co., Ltd. (China), among others.The vitamin K2 market witnesses increased scope for growth. The market is seeing an increase in the number of joint ventures, acquisitions, and new expansions. Moreover, the companies involved in manufacturing vitamin K2 products are investing a considerable proportion of their revenues in research and development activities.
Which region is projected to be the fastest growing in the vitamin K2 market?
The Asia Pacific market is expected to be the fastest-growing market. The expansion of the nutraceutical and functional food industries in the Asia Pacific region is playing a crucial role in the rapid growth of the Vitamin K2 market. There is a burgeoning demand for functional foods and beverages that offer additional health benefits beyond basic nutrition.
What kind of information is provided in the company profile section?
The company profiles mentioned above offer valuable information, such as a comprehensive business overview, including details on the company's various business segments, financial performance, geographical reach, revenue composition, and the breakdown of their business revenue. Additionally, these profiles offer insights into the company's product offerings, significant milestones, and expert analyst perspectives to further explain the company's potential.
What are the factors driving the vitamin K2 market?
The Vitamin K2 market is driven by several key factors, including increasing awareness of its health benefits, especially in bone and cardiovascular health. Growing consumer interest in preventive healthcare, coupled with the rise in disposable incomes, has led to increased spending on dietary supplements. Additionally, advancements in scientific research validating Vitamin K2’s efficacy, along with innovations in supplement formulations that enhance bioavailability, contribute to the market’s growth.

 

 

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Vitamin K2 Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
23
RESEARCH METHODOLOGY
29
EXECUTIVE SUMMARY
42
PREMIUM INSIGHTS
47
MARKET OVERVIEW
51
  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    RISING GDP AND POPULATION
    RISE IN HEALTH CONCERNS AND DISEASE INCIDENCES
    INCREASE IN HEALTHCARE EXPENDITURE AND PREVENTIVE HEALTHCARE TRENDS
  • 5.3 MARKET DYNAMICS
    DRIVERS
    - Rising health consciousness among consumers
    - Growing research and development activities
    RESTRAINTS
    - Inconsistency in regulatory norms
    - Price volatility of raw materials
    OPPORTUNITIES
    - Growing demand for natural and plant-based ingredients
    - Rising need for personalized nutrition and customized products
    - Untapped applications
    CHALLENGES
    - Lack of consumer awareness regarding specific health benefits of Vitamin K2
    - High research and development costs
INDUSTRY TRENDS
61
  • 6.1 INTRODUCTION
  • 6.2 SUPPLY CHAIN ANALYSIS
  • 6.3 VALUE CHAIN ANALYSIS
    RAW MATERIAL SOURCING
    MANUFACTURING AND PROCESSING
    PRODUCT FORMULATION AND DEVELOPMENT
    QUALITY ASSURANCE AND CERTIFICATION
    MARKETING AND DISTRIBUTION
  • 6.4 TRADE ANALYSIS
    EXPORT SCENARIO
    IMPORT SCENARIO
    HS CODE FOR VITAMIN K2 WITH PRODUCT DESCRIPTION
  • 6.5 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGY
    - Fermentation technology
    COMPLEMENTARY TECHNOLOGY
    - Encapsulation technology
    ADJACENT TECHNOLOGY
    - Biotechnology
  • 6.6 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND BY PRODUCT TYPE
    AVERAGE SELLING PRICE TREND, BY REGION
  • 6.7 ECOSYSTEM ANALYSIS
    DEMAND SIDE
    SUPPLY SIDE
  • 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 6.9 PATENT ANALYSIS
    LIST OF MAJOR PATENTS
  • 6.10 KEY CONFERENCES AND EVENTS, 2024–2025
  • 6.11 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    - Regulations in North America
    - Regulations in Europe
    - Regulations in Asia Pacific
  • 6.12 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
  • 6.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 6.14 CASE STUDY ANALYSIS
    ESTABLISHING DISTINCT RECOMMENDED DIETARY INTAKE TO PROMOTE HEALTHIER DIETARY CHOICES
    ENHANCING ABILITY IN NUTRACEUTICAL FORMULATIONS FOR IMPROVED QUALITY AND EFFICACY
  • 6.15 INVESTMENT AND FUNDING SCENARIO
VITAMIN K2 MARKET, BY FUNCTION
100
  • 7.1 INTRODUCTION
  • 7.2 BONE AND CARDIOVASCULAR HEALTH
    COMPREHENSIVE HEALTH BENEFITS TO DRIVE MARKET
  • 7.3 BLOOD HEALTH AND CLOTTING
    EFFICACY IN MANAGING CLOTTING DISORDERS TO BOOST MARKET GROWTH
  • 7.4 ANTI-INFLAMMATORY AND IMMUNITY
    THERAPEUTIC POTENTIAL AND IMMUNITY-SUPPORTING PROPERTIES TO SUPPORT MARKET GROWTH
  • 7.5 OTHER FUNCTIONS
VITAMIN K2 MARKET, BY PRODUCT TYPE
103
  • 8.1 INTRODUCTION
  • 8.2 MK-7
    HIGH BIOAVAILABILITY TO PROPEL MARKET GROWTH
  • 8.3 MK-4
    POTENTIAL BENEFITS IN BONE AND CARDIOVASCULAR HEALTH TO DRIVE MARKET GROWTH
VITAMIN K2 MARKET, BY APPLICATION FORM
111
  • 9.1 INTRODUCTION
  • 9.2 CAPSULES AND TABLETS
    ABILITY TO CATER TO DIVERSE CONSUMER NEEDS AND PREFERENCES TO DRIVE MARKET
  • 9.3 POWDER AND CRYSTALLINE
    SURGING DEMAND FOR CUSTOMIZABLE DOSAGES AND HIGH PURITY TO PROPEL MARKET GROWTH
  • 9.4 LIQUIDS
    GROWING NEED FOR SUPPLEMENTS WITH ENHANCED BIOAVAILABILITY TO BOOST SEGMENT GROWTH
VITAMIN K2 MARKET, BY SOURCE
116
  • 10.1 INTRODUCTION
  • 10.2 NATURAL ORIGIN
    INCREASING CONSUMER PREFERENCE FOR NON-GMO SUPPLEMENTS TO BOOST MARKET GROWTH
  • 10.3 SYNTHETIC ORIGIN
    LOW PRODUCTION COST TO DRIVE MARKET
VITAMIN K2 MARKET, BY APPLICATION
120
  • 11.1 INTRODUCTION
  • 11.2 HEALTH SUPPLEMENTS
    INCREASED AWARENESS REGARDING ASSOCIATED HEALTH BENEFITS TO DRIVE MARKET
  • 11.3 FUNCTIONAL FOODS AND BEVERAGES
    GROWING DEMAND FOR FORTIFIED FUNCTIONAL FOODS TO PROPEL MARKET GROWTH
  • 11.4 PHARMACEUTICALS
    RISING GOVERNMENT INVESTMENTS IN DEVELOPMENT OF NEW FORMULATIONS TO DRIVE MARKET
VITAMIN K2 MARKET, BY REGION
129
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT ANALYSIS
    US
    - Growing awareness regarding importance of preventive health measures to drive market
    CANADA
    - Increasing focus on preventive healthcare and natural products to propel market
    MEXICO
    - High prevalence of chronic lifestyle diseases to drive market
  • 12.3 EUROPE
    EUROPE: RECESSION IMPACT ANALYSIS
    GERMANY
    - Rising focus on proactive healthcare to drive market
    FRANCE
    - Innovative products and investments in research and development to boost market growth
    UK
    - Rapidly aging population to propel market growth
    ITALY
    - Evolving dietary preferences to boost market growth
    SPAIN
    - Growing consumer interest in health supplements to propel drive demand
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT ANALYSIS
    CHINA
    - Surging use of digital media to disseminate healthcare information to propel market
    JAPAN
    - Consumer preferences for natural healthcare solutions to boost market growth
    INDIA
    - Strategic market penetration initiatives by various companies to drive market
    AUSTRALIA AND NEW ZEALAND
    - Changing consumer preferences and increasing health consciousness to drive demand
    REST OF ASIA PACIFIC
  • 12.5 ROW
    ROW: RECESSION IMPACT ANALYSIS
    SOUTH AMERICA
    - Collaboration among key market players to drive market growth
    MIDDLE EAST AND AFRICA
    - Developing regulatory landscape to propel market growth
COMPETITIVE LANDSCAPE
170
  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 13.3 MARKET SHARE ANALYSIS
  • 13.4 COMPANY VALUATION AND FINANCIAL METRICS
    COMPANY VALUATION
    EV/EBITDA
  • 13.5 BRAND/PRODUCT COMPARISON ANALYSIS
  • 13.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Regional footprint
    - Product type footprint
    - Application footprint
  • 13.7 COMPANY EVALUATION MATRIX: DISTRIBUTORS/SUPPLIERS
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
    - Detailed list of key distributors/suppliers
    - Competitive benchmarking of key distributors/suppliers
  • 13.8 COMPETITIVE SCENARIO AND TRENDS
    PRODUCT LAUNCHES AND DEVELOPMENTS
    DEALS
    EXPANSIONS
    OTHERS
COMPANY PROFILES
191
  • 14.1 KEY PLAYERS (MANUFACTURERS)
    GNOSIS BY LESAFFRE (NATTOPHARMA)
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    KAPPA BIOSCIENCE AS (BALCHEM CORP.)
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.) (PLT HEALTH SOLUTIONS, INC.) (JAPAN)
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    NOVOZYMES A/S, PART OF NOVONESIS GROUP
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    SUNGEN BIOSCIENCE CO., LTD
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    VESTA NUTRA
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    MENADIONA
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    GF FERMENTECH (GENOFOCUS)
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    ANGELYEAST CO., LTD.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    GENEFERM BIOTECHNOLOGY CO., LTD.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    NAKODA CHEMICALS LTD.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    HAIHANG INDUSTRY CO., LTD.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    CHEMICEA LIMITED
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    KYOWA HAKKO U.S.A., INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
  • 14.2 DISTRIBUTORS/SUPPLIERS
    SEEBIO BIOTECH (SHANGHAI) CO., LTD.
    MAGNESIA GMBH
    FALCON TRADING INTERNATIONAL
    ABCO INDIA
    ATLANTIC CHEMICALS TRADING GMBH
ADJACENT AND RELATED MARKETS
234
  • 15.1 INTRODUCTION
  • 15.2 LIMITATIONS
  • 15.3 DIETARY SUPPLEMENTS MARKET
    MARKET DEFINITION
    MARKET OVERVIEW
  • 15.4 VITAMINS MARKET
    MARKET DEFINITION
    MARKET OVERVIEW
APPENDIX
238
  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 APPLICATION: OVERVIEW
  • TABLE 2 INCLUSIONS AND EXCLUSIONS
  • TABLE 3 USD EXCHANGE RATES, 2020–2023
  • TABLE 4 VITAMIN K2 MARKET SNAPSHOT, 2024 VS. 2029
  • TABLE 5 TOP 10 EXPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019–2023 (USD THOUSAND)
  • TABLE 6 TOP 10 EXPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019–2023 (TON)
  • TABLE 7 TOP 10 IMPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019–2023 (USD THOUSAND)
  • TABLE 8 TOP 10 IMPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019–2023 (TON)
  • TABLE 9 HS CODE: PRODUCT DESCRIPTION
  • TABLE 10 TRADE DATA FOR VITAMIN K2, 2023
  • TABLE 11 LEADING IMPORTING AND EXPORTING COUNTRIES, 2023
  • TABLE 12 AVERAGE SELLING PRICE (ASP), BY PRODUCT TYPE, 2020–2023 (USD/TON)
  • TABLE 13 AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2023 (USD/TON)
  • TABLE 14 VITAMIN K2 MARKET ECOSYSTEM
  • TABLE 15 LIST OF MAJOR PATENTS PERTAINING TO VITAMIN K2, 2020–2023
  • TABLE 16 VITAMIN K2 MARKET: KEY DETAILED LIST OF CONFERENCES AND EVENTS, 2024–2025
  • TABLE 17 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 IMPACT OF PORTER’S FIVE FORCES ON VITAMIN K2 MARKET
  • TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
  • TABLE 22 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
  • TABLE 23 PRODUCT TYPE: OVERVIEW
  • TABLE 24 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 25 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 26 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON)
  • TABLE 27 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON)
  • TABLE 28 MK-7: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 29 MK-7: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 30 MK-7: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 31 MK-7: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 32 MK-7: VITAMIN K2 MARKET, BY REGION, 2020–2023 (TON)
  • TABLE 33 MK-7: VITAMIN K2 MARKET, BY REGION, 2024–2029 (TON)
  • TABLE 34 MK-4: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 35 MK-4: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 36 MK-4: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 37 MK-4: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 38 MK-4: VITAMIN K2 MARKET, BY REGION, 2020–2023 (TON)
  • TABLE 39 MK-4: VITAMIN K2 MARKET, BY REGION, 2024–2029 (TON)
  • TABLE 40 VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION)
  • TABLE 41 VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION)
  • TABLE 42 CAPSULES AND TABLETS: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 43 CAPSULES AND TABLETS: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 44 POWDER AND CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 45 POWDER AND CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 46 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 47 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 48 VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION)
  • TABLE 49 VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
  • TABLE 50 NATURAL: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 51 NATURAL: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 52 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 53 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 54 VITAMIN K2 MARKET: BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 55 VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 56 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 57 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 58 HEALTH SUPPLEMENTS: MK-7 VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 59 HEALTH SUPPLEMENTS: MK-7 VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 60 HEALTH SUPPLEMENTS: MK-4 VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 61 HEALTH SUPPLEMENTS: MK-4 VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 62 FUNCTIONAL FOODS AND BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 63 FUNCTIONAL FOODS AND BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 64 FUNCTIONAL FOODS AND BEVERAGES: MK-7 VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 65 FUNCTIONAL FOODS AND BEVERAGES: MK-7 VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 66 FUNCTIONAL FOODS AND BEVERAGES: MK-4 VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 67 FUNCTIONAL FOODS AND BEVERAGES: MK-4 VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 68 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 69 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 70 PHARMACEUTICALS: MK-7 VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 71 PHARMACEUTICALS: MK-7 VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 72 PHARMACEUTICALS: MK-4 VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 73 PHARMACEUTICALS: MK-4 VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 74 VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 75 VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 76 VITAMIN K2 MARKET, BY REGION, 2020–2023 (TON)
  • TABLE 77 VITAMIN K2 MARKET, BY REGION, 2024–2029 (TON)
  • TABLE 78 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 79 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (TON)
  • TABLE 81 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (TON)
  • TABLE 82 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 83 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON)
  • TABLE 85 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON)
  • TABLE 86 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION)
  • TABLE 87 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION)
  • TABLE 89 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 91 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: MK-7 VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 93 NORTH AMERICA: MK-7 VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: MK-4 VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 95 NORTH AMERICA: MK-4 VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 96 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 97 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 98 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 99 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 100 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 101 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 102 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 103 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 104 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (TON)
  • TABLE 105 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (TON)
  • TABLE 106 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 107 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 108 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON)
  • TABLE 109 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON)
  • TABLE 110 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION)
  • TABLE 111 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION)
  • TABLE 112 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION)
  • TABLE 113 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
  • TABLE 114 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 115 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 116 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 117 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 118 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 119 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 120 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 121 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 122 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 123 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 124 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 125 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 126 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 127 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (TON)
  • TABLE 131 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (TON)
  • TABLE 132 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON)
  • TABLE 135 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON)
  • TABLE 136 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: MK-7 VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: MK-7 VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: MK-4 VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: MK-4 VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 146 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 147 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 148 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 149 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 150 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 151 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 152 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 153 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 154 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 155 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 156 ROW: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION)
  • TABLE 157 ROW: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 158 ROW: VITAMIN K2 MARKET, BY REGION, 2020–2023 (TON)
  • TABLE 159 ROW: VITAMIN K2 MARKET, BY REGION, 2024–2029 (TON)
  • TABLE 160 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 161 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 162 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON)
  • TABLE 163 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON)
  • TABLE 164 ROW: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION)
  • TABLE 165 ROW: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION)
  • TABLE 166 ROW: VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION)
  • TABLE 167 ROW: VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
  • TABLE 168 ROW: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 169 ROW: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 170 ROW: MK-7 VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 171 ROW: MK-7 VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 172 ROW: MK-4 VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 173 ROW: MK-4 VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 174 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 175 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 176 MIDDLE EAST AND AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
  • TABLE 177 MIDDLE EAST AND AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  • TABLE 178 OVERVIEW OF STRATEGIES ADOPTED BY KEY VITAMIN K2 VENDORS
  • TABLE 179 VITAMIN K2 MARKET: DEGREE OF COMPETITION
  • TABLE 180 VITAMIN K2 MARKET: REGIONAL FOOTPRINT
  • TABLE 181 VITAMIN K2 MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 182 VITAMIN K2 MARKET: APPLICATION FOOTPRINT
  • TABLE 183 VITAMIN K2 MARKET: DETAILED LIST OF KEY DISTRIBUTORS/SUPPLIERS, 2023
  • TABLE 184 VITAMIN K2 MARKET: COMPETITIVE BENCHMARKING OF KEY DISTRIBUTORS/SUPPLIERS
  • TABLE 185 VITAMIN K2 MARKET: PRODUCT LAUNCHES AND DEVELOPMENTS, JANUARY 2020–JUNE 2024
  • TABLE 186 VITAMIN K2 MARKET: DEALS, JANUARY 2020–JUNE 2024
  • TABLE 187 VITAMIN K2 MARKET: EXPANSIONS, JANUARY 2020–JUNE 2024
  • TABLE 188 VITAMIN K2 MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2024
  • TABLE 189 GNOSIS BY LESAFFRE (NATTOPHARMA): COMPANY OVERVIEW
  • TABLE 190 GNOSIS BY LESAFFRE (NATTOPHARMA): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 191 GNOSIS BY LESAFFRE (NATTOPHARMA): PRODUCT LAUNCHES AND DEVELOPMENTS
  • TABLE 192 GNOSIS BY LESAFFRE (NATTOPHARMA): DEALS
  • TABLE 193 GNOSIS BY LESAFFRE (NATTOPHARMA): OTHER DEALS/DEVELOPMENTS
  • TABLE 194 KAPPA BIOSCIENCE AS (BALCHEM CORP.): COMPANY OVERVIEW
  • TABLE 195 KAPPA BIOSCIENCE AS (BALCHEM CORP.): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 196 KAPPA BIOSCIENCE AS (BALCHEM CORP.): PRODUCT LAUNCHES AND DEVELOPMENTS
  • TABLE 197 KAPPA BIOSCIENCE AS (BALCHEM CORP.): DEALS
  • TABLE 198 KAPPA BIOSCIENCE AS (BALCHEM CORP.): EXPANSIONS
  • TABLE 199 KAPPA BIOSCIENCE AS (BALCHEM CORP.): OTHER DEALS/DEVELOPMENTS
  • TABLE 200 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.) (PLT HEALTH SOLUTIONS, INC.): COMPANY OVERVIEW
  • TABLE 201 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.) (PLT HEALTH SOLUTIONS, INC.): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 202 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.) (PLT HEALTH SOLUTIONS, INC.: PRODUCT LAUNCHES AND DEVELOPMENTS
  • TABLE 203 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): DEALS
  • TABLE 204 NOVOZYMES A/S, PART OF NOVONESIS GROUP: COMPANY OVERVIEW
  • TABLE 205 NOVOZYMES A/S, PART OF NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 206 NOVOZYMES A/S, PART OF NOVONESIS GROUP: DEALS
  • TABLE 207 NOVOZYMES A/S, PART OF NOVONESIS GROUP: OTHER DEALS/DEVELOPMENTS
  • TABLE 208 SUNGEN BIOSCIENCE CO., LTD: COMPANY OVERVIEW
  • TABLE 209 SUNGEN BIOSCIENCE CO., LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 210 SUNGEN BIOSCIENCE CO., LTD: EXPANSIONS
  • TABLE 211 VESTA NUTRA: COMPANY OVERVIEW
  • TABLE 212 VESTA NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 213 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 214 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 215 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES AND DEVELOPMENTS
  • TABLE 216 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS
  • TABLE 217 MENADIONA: COMPANY OVERVIEW
  • TABLE 218 MENADIONA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 219 MENADIONA: PRODUCT LAUNCHES AND DEVELOPMENTS
  • TABLE 220 GF FERMENTECH (GENOFOCUS): COMPANY OVERVIEW
  • TABLE 221 GF FERMENTECH (GENOFOCUS): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 222 GF FERMENTECH (GENOFOCUS): PRODUCT LAUNCHES AND DEVELOPMENTS
  • TABLE 223 GF FERMENTECH (GENOFOCUS): DEALS
  • TABLE 224 ANGELYEAST CO., LTD.: COMPANY OVERVIEW
  • TABLE 225 ANGELYEAST CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 226 ANGELYEAST CO., LTD.: EXPANSIONS
  • TABLE 227 GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 228 GENEFERM BIOTECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 229 NAKODA CHEMICALS LTD.: COMPANY OVERVIEW
  • TABLE 230 NAKODA CHEMICALS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 231 HAIHANG INDUSTRY CO., LTD.: COMPANY OVERVIEW
  • TABLE 232 HAIHANG INDUSTRY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 233 CHEMICEA LIMITED: COMPANY OVERVIEW
  • TABLE 234 CHEMICEA LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 235 KYOWA HAKKO U.S.A., INC.: BUSINESS OVERVIEW
  • TABLE 236 KYOWA HAKKO U.S.A., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 237 SEEBIO BIOTECH (SHANGHAI) CO., LTD.: COMPANY OVERVIEW
  • TABLE 238 MAGNESIA GMBH: COMPANY OVERVIEW
  • TABLE 239 FALCON TRADING INTERNATIONAL: COMPANY OVERVIEW
  • TABLE 240 ABCO INDIA: COMPANY OVERVIEW
  • TABLE 241 ATLANTIC CHEMICALS TRADING GMBH: COMPANY OVERVIEW
  • TABLE 242 ADJACENT MARKETS TO VITAMIN K2 MARKET
  • TABLE 243 DIETARY SUPPLEMENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
  • TABLE 244 DIETARY SUPPLEMENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
  • TABLE 245 VITAMINS MARKET, BY REGION, 2017–2022 (USD MILLION)
  • TABLE 246 VITAMINS MARKET, BY REGION, 2023–2028 (USD MILLION)
LIST OF FIGURES
 
  • FIGURE 1 VITAMIN K2 MARKET: RESEARCH DESIGN
  • FIGURE 2 VITAMIN K2 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 3 VITAMIN K2 MARKET SIZE CALCULATION: SUPPLY-SIDE ANALYSIS
  • FIGURE 4 VITAMIN K2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 5 DATA TRIANGULATION
  • FIGURE 6 INDICATORS OF RECESSION
  • FIGURE 7 GLOBAL INFLATION RATE, 2012–2022
  • FIGURE 8 GLOBAL GROSS DOMESTIC PRODUCT, 2012–2022 (USD TRILLION)
  • FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON VITAMIN K2 MARKET
  • FIGURE 10 GLOBAL VITAMIN K2 MARKET: CURRENT FORECAST VS. RECESSION FORECAST
  • FIGURE 11 MK-7 SEGMENT TO HOLD LARGER MARKET SIZE IN 2024
  • FIGURE 12 CAPSULES AND TABLETS TO BE LARGEST APPLICATION FORM SEGMENT IN 2024
  • FIGURE 13 NATURAL SOURCE SEGMENT TO DOMINATE MARKET IN 2024
  • FIGURE 14 PHARMACEUTICALS APPLICATION SEGMENT TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 15 ASIA PACIFIC PROJECTED TO BE THE FASTEST GROWING REGION
  • FIGURE 16 GROWING CONSUMER PREFERENCES FOR NATURAL AND ORGANIC PRODUCTS TO DRIVE DEMAND FOR VITAMIN K2
  • FIGURE 17 MK-7 SEGMENT AND US TO ACCOUNT FOR SIGNIFICANT MARKET SHARES IN 2024
  • FIGURE 18 US ACCOUNTED FOR LARGEST SHARE IN 2023
  • FIGURE 19 MK-7 SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 20 CAPSULES AND TABLETS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 21 NATURAL SEGMENT TO ACCOUNT FOR LARGER MARKET SIZE DURING FORECAST PERIOD
  • FIGURE 22 HEALTH SUPPLEMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 23 GLOBAL POPULATION GROWTH, 1950–2050 (BILLION)
  • FIGURE 24 GDP GROWTH, 2016–2023 (USD TRILLION)
  • FIGURE 25 GLOBAL TRENDS IN DEATHS DUE TO CVD, 1990-2030
  • FIGURE 26 VITAMIN K2 MARKET: MARKET DYNAMICS
  • FIGURE 27 OECD HEALTH SPENDING AS SHARE OF GDP, 2017–2021
  • FIGURE 28 GLOBAL EXPANSION OF VITAMIN K2 RESEARCH OVER THREE DECADES (1990–2020)
  • FIGURE 29 VITAMIN K2 MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 30 VALUE CHAIN ANALYSIS: VITAMIN K2 MARKET
  • FIGURE 31 EXPORT VALUE OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629) FOR KEY COUNTRIES, 2019–2023 (USD THOUSAND)
  • FIGURE 32 IMPORT VALUE OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629) FOR KEY COUNTRIES, 2019–2023 (USD THOUSAND)
  • FIGURE 33 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE, 2020–2023 (USD/TON)
  • FIGURE 34 KEY PLAYERS IN VITAMIN K2 ECOSYSTEM
  • FIGURE 35 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 36 NUMBER OF PATENTS GRANTED FOR VITAMIN K2 MARKET, 2013–2023
  • FIGURE 37 REGIONAL ANALYSIS OF PATENTS GRANTED FOR VITAMIN K2 MARKET, 2013–2023
  • FIGURE 38 PORTER’S FIVE FORCES ANALYSIS: VITAMIN K2 MARKET
  • FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
  • FIGURE 40 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
  • FIGURE 41 INVESTMENT AND FUNDING SCENARIO, 2019–2024 (USD MILLION)
  • FIGURE 42 MK-7 SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
  • FIGURE 43 CAPSULES AND TABLETS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 44 NATURAL ORIGIN SEGMENT TO ACCOUNT FOR LARGER MARKET SIZE DURING FORECAST PERIOD
  • FIGURE 45 HEALTH SUPPLEMENTS SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
  • FIGURE 46 ITALY TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 47 NORTH AMERICA VITAMIN K2 MARKET SNAPSHOT
  • FIGURE 48 INFLATION IN NORTH AMERICA: COUNTRY-LEVEL DATA, 2017–2022
  • FIGURE 49 NORTH AMERICA: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
  • FIGURE 50 INFLATION IN EUROPE: COUNTRY-LEVEL DATA, 2017-2022
  • FIGURE 51 EUROPE: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
  • FIGURE 52 ASIA PACIFIC VITAMIN K2 MARKET SNAPSHOT
  • FIGURE 53 INFLATION IN ASIA PACIFIC: COUNTRY-LEVEL DATA, 2017-2022
  • FIGURE 54 ASIA PACIFIC: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
  • FIGURE 55 INFLATION IN ROW, COUNTRY-LEVEL DATA, 2017-2022
  • FIGURE 56 ROW: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
  • FIGURE 57 SHARE OF LEADING COMPANIES IN VITAMIN K2 MARKET, 2023
  • FIGURE 58 COMPANY VALUATION OF KEY VITAMIN K2 VENDORS, 2023 (USD BILLION)
  • FIGURE 59 EV/EBITDA OF KEY COMPANIES, 2023
  • FIGURE 60 BRAND/PRODUCT COMPARISON ANALYSIS, BY PRODUCT TYPE
  • FIGURE 61 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 62 VITAMIN K2 MARKET: COMPANY FOOTPRINT
  • FIGURE 63 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (DISTRIBUTORS/SUPPLIERS), 2023
  • FIGURE 64 KAPPA BIOSCIENCE AS (BALCHEM CORP.): COMPANY SNAPSHOT
  • FIGURE 65 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.) (PLT HEALTH SOLUTIONS, INC.): COMPANY SNAPSHOT
  • FIGURE 66 NOVOZYMES A/S, PART OF NOVONESIS GROUP: COMPANY SNAPSHOT

The study involved in estimating the current size of the vitamin k2 market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

This research study involved the extensive use of secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial study of the vitamin k2 market.

In the secondary research process, various sources such as annual reports, press releases & investor presentations of companies, white papers, food journals, certified publications, articles from recognized authors, directories, and databases, were referred to identify and collect information.

Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, and market classification and segmentation as per the industry trends to the bottom-most level, regional markets, and key developments from both market- and technology-oriented perspectives.

Primary Research

Extensive primary research was conducted after obtaining information regarding the vitamin k2 market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, and the Rest of the World. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, research, and development teams, and related key executives from distributors, and key opinion leaders. Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to vitamin k2 product type, form, source, application, function, and region. Stakeholders from the demand side, such as pharmaceutical and food  & beverage manufacturers who use vitamin K2, were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage of vitamin k2 and the outlook of their business, which will affect the overall market.

Vitamin K2 Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

designation

Gnosis by Lesaffre (NattoPharma) (Norway)

Regional Sales Manager

Kappa Bioscience (Balchem Corp.) (US)

Marketing Manager

Sungen Bioscience Co., Ltd (China)

General Manager

Vesta Nutra (US)

Sales Manager

J-OIL MILLS, INC. (Japan)

Sales Manager

Novozymes A/S (Denmark)

Sales Executive

Vitamin K2 Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total market size. These approaches were also used to estimate the size of various dependent submarkets. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets were identified through extensive secondary research.
  • All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the markets covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
  • The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.

Global Vitamin K2 Market: Bottom-Up Approach.

Vitamin K2 Market Bottom Up Approach

To know about the assumptions considered for the study, Request for Free Sample Report

Global Vitamin K2 Market: Top-Down Approach.

Vitamin K2 Market Top Down Approach

Data Triangulation

After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. To estimate the overall vitamin k2 market and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.

Market Definition

According to the National Institutes of Health (NIH) Office of Dietary Supplements (ODS), Vitamin K2, also called menaquinone (MK), is one of the groups of fat-soluble vitamins that play a role in blood clotting and bone health. MK-4 and MK-7 are two specific subtypes of vitamin K2, also known as menaquinone. Both MK-4 and MK-7 are found naturally in some foods and can be taken as supplements. They both play a role in blood clotting and bone health by activating proteins like osteocalcin and matrix Gla protein (MGP).

Key Stakeholders

  • Vitamins manufacturers
  • Vitamins traders, distributors, and suppliers
  • Food processors & food manufacturers
  • Regulatory bodies:
    • Food and Drug Administration (FDA)
    • European Commission
    • European Food Safety Authority (EFSA)
    • Food Standards Australia New Zealand (FSANZ 
  • Associations, and commercial research & development (R&D) institutions:
  • Importers and exporters of vitamins
  • Global Alliance for Improved Nutrition (GAIN)
  • Food Fortification Initiative (FFI)
  • Food and Agriculture Organization (FAO)
  • United Nations International Children's Emergency Fund (UNICEF)
  • World Health Organization (WHO)
  • World Organization for Animal Health (WOAH)

Report Objectives

  • To define, segment, and forecast the global vitamin K2 market based on product types, forms, sources, function (qualitative), applications, and regions over a historical period from 2020 to 2023 and a forecast period from 2024 to 2029
  • To provide detailed information about the key factors influencing the market's growth (drivers, restraints, opportunities, and challenges).
  • To identify attractive opportunities in the market by determining the largest and fastest-growing segments across the regions.
  • To analyze the demand-side factors based on the following:
    • Impact of macro and microeconomic factors on the market
    • Shifts in demand patterns across different subsegments and regions
  • To strategically profile the key players and comprehensively analyze their core competencies.
  • To analyze competitive developments, such as partnerships, mergers & acquisitions, new product developments, and expansions & investments in the vitamin K2 market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company.

Geographic Analysis

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

  • Further breakdown of the Rest of the European vitamin k2 market into key countries
  • Further breakdown of the Rest of Asia Pacific vitamin k2 market into key countries

Company Information

  • Detailed analyses and profiling of additional market players (up to five)

Previous Versions of this Report

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Vitamin K2 Market

DMCA.com Protection Status